(SUPN) Supernus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Supernus Pharmaceuticals | (SUPN) share price targets
Complete technical analysis of Supernus Pharmaceuticals (SUPN) by charts plus indicators, forecast predictions and share price targets for Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Supernus Pharmaceuticals is 654310
| Date | Daily Closing Price | Open | High | Low | Volume |
| 08 Mon Dec 2025 | 47.16 | 46.32 | 47.26 | 45.75 | 1.405 times |
| 05 Fri Dec 2025 | 45.68 | 44.94 | 45.88 | 44.51 | 0.701 times |
| 04 Thu Dec 2025 | 45.10 | 44.76 | 45.10 | 44.28 | 0.754 times |
| 03 Wed Dec 2025 | 44.76 | 44.27 | 45.07 | 44.21 | 0.806 times |
| 02 Tue Dec 2025 | 44.12 | 44.70 | 44.90 | 44.09 | 0.954 times |
| 01 Mon Dec 2025 | 44.70 | 45.38 | 45.58 | 44.65 | 0.864 times |
| 28 Fri Nov 2025 | 45.59 | 46.39 | 46.57 | 45.53 | 0.662 times |
| 26 Wed Nov 2025 | 46.26 | 46.14 | 47.00 | 45.72 | 1.512 times |
| 25 Tue Nov 2025 | 46.08 | 45.62 | 46.79 | 45.16 | 1.519 times |
| 24 Mon Nov 2025 | 45.15 | 45.50 | 46.00 | 45.00 | 1.255 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 46.8, for a target of 46 or 45.3
Share price targets for Supernus Pharmaceuticals (SUPN)
| Target Type | Value |
| Downside Target | 34.64 |
| Downside Target | 43.11 |
| Downside Target | 46.47 |
| Downside Target | 46.59 |
| Downside Target | 47.00 |
| Upside Target | 47.26 |
| Upside Target | 47.27 |
| Upside Target | 48.44 |
| Upside Target | 57.40 |
| Upside Target | 57.65 |
Intraday share price targets for Supernus Pharmaceuticals (SUPN)
| Target Type | Value |
| Downside Intraday Target | 46.19 |
| Downside Intraday Target | 45.21 |
| Upside Intraday Target | 47.7 |
| Upside Intraday Target | 48.23 |
| Downside Intraday Target | 46.72 |
Weekly technical analysis of Supernus Pharmaceuticals (SUPN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 08 Mon Dec 2025 | 47.16 | 46.32 | 47.26 | 45.75 | 0.344 times |
| 05 Fri Dec 2025 | 45.68 | 45.38 | 45.88 | 44.09 | 0.824 times |
| 28 Fri Nov 2025 | 45.59 | 45.50 | 47.00 | 45.00 | 0.943 times |
| 21 Fri Nov 2025 | 45.32 | 45.30 | 46.47 | 44.05 | 0.637 times |
| 14 Fri Nov 2025 | 45.00 | 46.08 | 46.59 | 44.12 | 0.811 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Supernus Pharmaceuticals (SUPN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 08 Mon Dec 2025 | 47.16 | 45.38 | 47.26 | 44.09 | 0.192 times |
| 28 Fri Nov 2025 | 45.59 | 55.43 | 57.40 | 43.11 | 0.985 times |
| 31 Fri Oct 2025 | 55.13 | 47.62 | 57.65 | 47.27 | 1.312 times |
| 30 Tue Sep 2025 | 47.79 | 44.95 | 48.44 | 43.44 | 0.708 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Supernus Pharmaceuticals (SUPN)
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 45.62 and Supernus Pharmaceuticals (SUPN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 45.62 and Supernus Pharmaceuticals (SUPN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.